Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids

Food and Chemical Toxicology

Volumn 41, Issue 10, 2003, Pages 1291-1298

  Snyder, Ronald D ^a,c   Gillies, Peter J ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b DUPONT COMPANY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Flavonoids; Genistein; Genotoxicity; Topoisomerase II; V79

Indexed keywords

BIOCHANIN A; DAIDZEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); FISETIN; FLAVONOID; GALANGIN; GENISTEIN; GYRASE INHIBITOR; HESPERETIN; NARINGENIN; REACTIVE OXYGEN METABOLITE; DIACETYLDICHLOROFLUORESCEIN; DIAGNOSTIC AGENT; DIMETHYL SULFOXIDE; ENZYME INHIBITOR; FLUORESCEIN DERIVATIVE; ISOFLAVONE DERIVATIVE; MUTAGENIC AGENT;

ANIMAL CELL; ARTICLE; CELL STRAIN V 79; CHINESE HAMSTER; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; FOOD COMPOSITION; GENOTOXICITY; MICRONUCLEUS; NONHUMAN; ANIMAL; CELL LINE; CRICETULUS; DIET SUPPLEMENTATION; DRUG ANTAGONISM; HAMSTER; METABOLISM; MICRONUCLEUS TEST;

CRICETINAE; CRICETULUS GRISEUS;

ANIMALS; CELL LINE; CRICETINAE; CRICETULUS; DIETARY SUPPLEMENTS; DIMETHYL SULFOXIDE; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; FLAVONOIDS; FLUORESCEINS; GENISTEIN; ISOFLAVONES; MICRONUCLEUS TESTS; MUTAGENS; REACTIVE OXYGEN SPECIES;

EID: 0141543861     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(03)00117-0     Document Type: Article

References (44)

1. Afanas'Ev I.B., Dorozhko A.I., Brodskii A.V., Kostyuk A., Potopovitch A.I. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochemical Pharmacology. 38:1989;1763-1769.
2. Austin C.A., Patel S., Ono K., Nakane H., Fisher L.M. Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochemical Journal. 282:1992;883-889.
3. Bjeldanes F., Chang G.W. Mutagenic activity of quercetin and related compounds. Science. 197:1977;577-578.
4. Boos G., Stopper H. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicology Letters. 116:2000;7-16.
5. Bouker K.B., Hilakivi-Clarke L. Genistein. Does it prevent or promote breast cancer? Environmental Health Perspectives. 108:2000;701-708.
6. Brown J.E., Khodr H., Hider R.C., Rice-Evans C.A. Structural dependence of flavonoid interactions with Cu-2+ ions. implications for their antioxidant properties Biochemical Journal. 330:1998;1173-1178.
7. Busby M.G., Jeffcoat A.R., Bloedon L.T., Koch M.A., Black T., Dix K.J., Heizer W.D., Thomas B.F., Hill J.M., Crowell J.A., Zeisel S.H. Clinical characteristics and pharmacokinetics of purified soy isoflavones. single dose administration to healthy men American Journal of Clinical Nutrition. 75:2002;126-136.
8. Constantinou A., Mehta R., Runyan C., Rao K., Vaughan A., Moon R. Flavonoids as DNA topoisomerase antagonists and poisons. Structure-activity relationships Journal of Natural Products. 58:1995;217-225.
9. Duthie S.J., Johnson W., Dobson V.L. The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimidines) and growth in human cells. Mutation Research. 390:1997;141-1541.
10. Eldridge A., Kwolek W.F. Soybean isoflavones. Effect of environment and variety on composition Journal of Agriculture and Food Chemistry. 31:1983;394-396.
11. Fenech M., Morley A.A. Measurement of micronuclei in human lymphocytes. Mutation Research. 147:1985;29-36.
12. Franke A.A., Custer L.J., Cerna C.M., Narala K.K. Quantitation of phytoestrogens in legumes by HPLC. Journal of Agriculture and Food Chemistry. 42:1994;1905-1913.
13. Gaspar J., Rodrigues A., Laires A., Silva F., Costa S., Monteiro M.J., Monteiro C., Rueff J. On the mechanisms of genotoxicity and metabolism of quercetin. Mutagenesis. 9:1994;445-449.
14. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochemical Pharmacology. 32:1983;1141-1148.
15. Heo M.Y., Sohn S.J., Au W.W. Antigenotoxicity of galangin as a cancer chemopreventive agent candidate. Mutation Research. 488:2001;135-150.
16. Hodnick W.F., Kung F.S., Roettger W.A., Bohmont C.W., Pardini R.S. Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids. Biochemical Pharmacology. 352:1986;2345-2357.
17. Jensen P.B., Sehested M. DNA topoisomerase II rescue by catalytic inhibitors. a new strategy to improve the antitumor selectivity of etoposide Biochemical Pharmacology. 54:1997;755-759.
18. Kelloff G.J., Lieberman R., Steele V.E., Boone C.W., Lubet R.A., Kopelovitch L., Malone W.A., Crowell J.A., Sigman C.C. Chemoprevention of prostate cancer. Concepts and strategies European Journal of Urology. 35:1999;342-350.
19. Kulling S.E., Rosenberg B., Jacobs E., Metzler M. The phytoestrogens coumoestrol and genistein induce structural chromosome aberrations in cultured human peripheral blood lymphocytes. Archives of Toxicology. 73:1999;50-54.
20. Kulling S.E., Honig D.M., Simat T.J., Metzler M. Oxidative in vitro metabolism of the soy phytoestrogens daidzein and genistein. Journal of Agricultural and Food Chemistry. 48:2000;4963-4972.
21. MacGregor J.T., Wehr C.M., Manners G.D., Jurd L., Minkler J.L., Carrano A.V. In vivo exposure to plant flavonols. Influence on frequencies of micronuclei in mouse erythrocytes and sister-chromatid exchange in rabbit lymphocytes. Mutation Research. 124:1983;255-270.
22. Misra R.R., Hursting S.D., Perkins S.N., Sathyamoorthy N., Mirsalis J.C., Riccio E.S., Crowell J.A. Genotoxicity and carcinogenicity studies of soy isoflavones. International Journal of Toxicology. 21:2002;277-285.
23. Moon J.Y., Lee D.W., Park K.H. Inhibition of 7-ethoxycoumarin O-deethylase activity in rat liver microsomes by naturally occurring flavonoids. structure-activity relationships Xenobiotica. 28:1998;117-126.
24. Murphy P.A. Phytoestrogen content of processed soybean products. Food Technology. 34:1982;60-64.
25. Reinli K., Block G. Phytoestrogen content of foods. Nutrition and Cancer. 26:1996;123-148.
26. Ross J.A. Maternal diet and infant leukemia. A role for DNA topoisomerase II inhibitors International Journal of Cancer. 11:1998;26-28.
27. Ross J.A., Potter J.D., Reaman G.H., Pendergrass T.W., Robison L.L. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States). a report from the Children's Cancer Group Cancer Causes and Control. 7:1996;581-590.
28. Ross J.A., Potter J.D., Robison L.L. Infant leukemia, topoisomerase II inhibitors and the MLL gene. Journal of the National Cancer Institute. 86:1994;1678-1680.
29. Sahu R.K., Basu R., Sharma A. Genetic toxicological testing of some plant flavonoids by the micronucleus test. Mutation Research. 89:1981;69-74.
30. Setchell K.D.R. Phytoestrogens. the biochemistry, physiology, and implications for human health of soy isoflavones American Journal of Clinical Nutrition. 68:1998;1333S-1346S.
31. Setchell K.D.R., Brown N.M., Desai P., Zimmer-Nechemias L., Wolfe B.E., Brashear W.T., Kirschner A.S., Cassidy A., Heubi J.E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. Journal of Nutrition. 13:2001;1362S-1375S.
32. Silva I.D., Gaspar J., Gomes da Costa G., Rodrigues A.S., Laires A., Rueff J. Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents. Chemico-Biological Interactions. 124:2000;29-51.
33. Skibola C.F., Smith M.T. Potential health impacts of excessive flavonoid uptake. Free Radicals in Biology and Medicine. 29:2000;375-383.
34. Slater D.J., Hilgenfeld E., Rappaport E.F., Shah N., Meek R.G., Williams W.R., Lovett B.D., Osheroff N., Autur R.S., Reid T., Felix C.A. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3,X, and 11 in infant acute myeolomonocytic leukemia and in t(X;11) in infant acute myeloid leukemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site. Oncogene. 21:2002;4706-4714.
35. Snyder R.D., Gillies P.J. Evaluation of the clastogenic, DNA intercalative and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environmental and Molecular Mutagenesis. 40:2002;266-276.
36. Snyder R.D. Use of catalytic topoisomerase inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells. Environmental and Molecular Mutagenesis. 35:2000;13-21.
37. Snyder R.D., Arnone M.R. Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutation Research. 503:2002;21-35.
38. Snyder R.D., Grdina D.J. Further evidence that the radioprotective aminothiol, WR1065, catalytically inactivates mammalian topoisomerase II. Cancer Research. 60:2000;1186-1188.
39. Solimani R., Bayon F., Domini I., Pifferi P.G., Todesco P.E., Marconi G., Samori B. Flavonoid-DNA interaction studied with flow linear dichroism technique. Journal of Agricultural and Food Chemistry. 43:1995;876-882.
40. Strick R., Strissel P.L., Borgers S., Smith S.L., Rowley J.D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proceedings of the National Academy of Sciences of the USA. 97:2000;4790-4795.
41. Wang H., Joseph J.A. Quantifying cellular oxidative stress by diclorofluorescein assay using microplate reader. Free Radicals in Biology and Medicine. 27:1999;612-616.
42. Yamashita N., Tanemura H., Kawanishi S. Mechanism of oxidative DNA damage induced by quercetin in the presence of Cu(II). Mutation Research. 425:1999;107-115.
43. Yamashita Y., Kawada S.-Z., Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochemical Pharmacology. 39:1990;737-744.
44. Zhai S., Dai R., Friedman F.K., Vestal R.E. Comparative inhibition of human cytochromes p450 1a1 and 1a2 by flavonoids. Drug Metabolism and Disposition. 26:1998;989-992.